The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study

Recruiting Observational Study
Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Study type
Observational
Participants needed
3,100 (estimated)
Sponsor
Yonsei University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
1\. Purpose of the study 1\) To explore clinical recurrence associated clinical factors including age, sex, clinical, electrophysiological, anatomical, imaging, and serologic characteristics. 2\) To develop simulation model to predict clinical recurrence and the efficacy of catheter ablation 2. Scientific evidence of the study 1. In atrial fibrillation patients, the maintenance of normal sinus …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients who undergoing catheter ablation of atrial fibrillation due to symptomatic, drug refractory atrial fibrillation Exclusion Criteria: * patients who do not agree with study inclusion * permanent AF refractory to electrical cardioversion * AF with valvular disease ≥ gr…
Contacts

Hui-Nam Pak, MD

82-2-2228-8459

hnpak@yuhs.ac

CONTACT